Lei, X.; Wang, C.; Xia, M.; Zhang, G.; Wang, T.; Chen, Y.; Huang, Y.; Wang, T.; Li, D.; Zhang, W.;
et al. Anemoside B4 Rectal Thermosensitive In Situ Gel to Treat Ulcerative Colitis by Overcoming Oral Bioavailability Barriers with Absorption Enhancer-Assisted Delivery. Pharmaceutics 2025, 17, 1400.
https://doi.org/10.3390/pharmaceutics17111400
AMA Style
Lei X, Wang C, Xia M, Zhang G, Wang T, Chen Y, Huang Y, Wang T, Li D, Zhang W,
et al. Anemoside B4 Rectal Thermosensitive In Situ Gel to Treat Ulcerative Colitis by Overcoming Oral Bioavailability Barriers with Absorption Enhancer-Assisted Delivery. Pharmaceutics. 2025; 17(11):1400.
https://doi.org/10.3390/pharmaceutics17111400
Chicago/Turabian Style
Lei, Xiaomeng, Canjian Wang, Mingyan Xia, Guansheng Zhang, Tangxun Wang, Yang Chen, Yufang Huang, Tiantian Wang, Dongxun Li, Wenliu Zhang,
and et al. 2025. "Anemoside B4 Rectal Thermosensitive In Situ Gel to Treat Ulcerative Colitis by Overcoming Oral Bioavailability Barriers with Absorption Enhancer-Assisted Delivery" Pharmaceutics 17, no. 11: 1400.
https://doi.org/10.3390/pharmaceutics17111400
APA Style
Lei, X., Wang, C., Xia, M., Zhang, G., Wang, T., Chen, Y., Huang, Y., Wang, T., Li, D., Zhang, W., & Zhang, G.
(2025). Anemoside B4 Rectal Thermosensitive In Situ Gel to Treat Ulcerative Colitis by Overcoming Oral Bioavailability Barriers with Absorption Enhancer-Assisted Delivery. Pharmaceutics, 17(11), 1400.
https://doi.org/10.3390/pharmaceutics17111400